patent/CN-105130913-A

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_159936a9a847e1b85fb4d921ae15d764
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
filingDate	2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bcb4ce2c07706533757f51b0f91eaf8
publicationDate	2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CN-105130913-A
titleOfInvention	A class of multi-substituted benzoquinazoline tyrosine kinase inhibitors and uses thereof
abstract	The present invention relates to the field of tumor diseases. Specifically, the present invention relates to a class of multi-substituted benzoquinazoline tyrosine kinase inhibitors, its preparation method and its application in the preparation and treatment of tumor diseases. Wherein, X is selected from halogen substituents.
priorityDate	2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101648947-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010015523-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103608336-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101935316-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467849302

Total number of triples: 17.